MultNAT® Carba-R Assay
Ongoing Challanges
- CRE are difficult to treat because they do not respond to commonly used antibiotics. Occasionally, CRE are resistant to all available antibiotics. CRE is a threat to public health.
- Enterobacterales are a large order of different types of germs (bacteria) that commonly cause infections in healthcare settings. Enterobacterales bacteria are constantly finding new ways to avoid the effects of the antibiotics used to treat the infections they cause.
Product Overview
MultNAT® Carba-R Assay is intended for qualitative in vitro detection of carbapenem resistance genes (blaKPC, blaNDM, blaVIM, blaOXA, and blalMP) in rectal swab specimens.
- Result obtained within 86 mins
- Direct diagnosis design to provide an accurate LOD: 500 copies/mL
- Moderately complex testing with less than 1 min hands-on time
- Simplified workflow, realizing “sample in, result out”
- All-in-one cartridge, no cross-contamination
Clinical Value
- Swiftly detect CRE infections, expediting patient diagnosis and treatment
- Aid timely adjustment of treatment plans, enhancing treatment efficacy.
- Facilitate prompt identification of infections, enabling effective infection control measures and preventing disease spread.
- Save time and labor, improving the efficiency of medical resource utilization
Product Resources
MultNAT® Carba-R Assay Brochure
Brochure
MultNAT® Carba-R Assay Brochure
Instructions for Use
MultNAT® Carba-R Assay Brochure
SOP
